Endpoints NewsHammered on a gene therapy setback, Dimension cuts staff and circles the wagonsEndpoints NewsDimension Therapeutics is winnowing out 25% of its staff as it concentrates on three gene therapy programs, including one partnered with Bayer th… Continue reading
EurekAlert (press release) |
Trials show unique stem cells a potential asthma treatment
EurekAlert (press release) The Monash Biomedicine Discovery Institute (BDI) scientists provided the experimental expertise to test Cynata Therapeutics’ induced pluripotent stem cell-derived mesenchymal stem cells (MSCs) in a model of experimental asthma. Induced pluripotent stem … |
|
U.S. Patent Office to Confirm Kite’s Seminal Eshhar CAR-T Patent …
PharmiWeb.com (press release) Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the United States Patent and Trademark Office (USPTO) has provided a … |
|
Barrier Proteins in Tumors are Possible Key to Immunotherapy Success
Newswise (press release) Newswise — By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the … |
|
US Patent Office to Confirm Kite’s Seminal Eshhar CAR–T Patent
Business Wire (press release) SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the United States Patent and Trademark Office (USPTO) has provided a Notice of Intent to issue an Ex Parte Reexamination … |
Medical Xpress |
First ‘haploid’ human stem cells could change the face of medical research
Medical Xpress Haploid human embryonic stem cells. Credit: Azrieli Center for Stem Cells and Genetic Research at Hebrew University. Stem cell research holds huge potential for medicine and human health. In particular, human embryonic stem cells (ESCs), with their … |